Overview

A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple Myeloma

Status:
Terminated
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
To determine the overall response rate (CR+PR) of patients with relapsed or refractory multiple myeloma treated with clofarabine.
Phase:
Phase 2
Details
Lead Sponsor:
Washington University School of Medicine
Treatments:
Clofarabine